Original communicationTreatment outcomes of chemical castration on Korean sex offenders
Introduction
Attempts at using hormonal manipulation to control pathological sexual behaviour and to prevent sexual offenses have been reported since the 1940s.1 Recently, androgen-deprivation treatment (ADT), commonly referred to as chemical castration, has been employed as a supportive measure in addition to psychotherapy for treatment of sex offenders in many Western countries.2 Sexual offences are crimes that violate the integrity of the community and are of concern to the general public. As a result, legislation to prevent repeat offences has often been driven by both the public and the media. Despite evidence that chemical castration with or without psychotherapy can successfully reduce recidivism rates,3 the criminal justice systems in many countries are reticent to endorse this legislation given concerns regarding preservation of human rights, adverse effects and cost.3, 4 In response to ongoing public demands for implementation of community safety measures, the Ministry of Justice of Korea enacted a legislation in 2011 requiring chemical castration of sexual offenders whose victims are minors under the age of 16. Two chemical agents have been approved for sex offender treatment including an anti-androgen, cyproterone acetate (CPA), and a gonadotropin-releasing hormone (GnRH) agonist, leuprolide acetate (LA). While chemical castration has been mandatory for sex offenders since 2011, prior detainees at the National Forensic Hospital who were under consideration for parole or probation were candidates for voluntary treatment. In this study, we sought to report preliminary data on psychobehavioural and clinical outcomes of short-term ADT in Korean sex offenders.
Section snippets
Participants
This prospective cross-sectional analysis included 121 patients at the National Forensic Hospital who were imprisoned for sexual offenses. After a detailed explanation of the therapeutic effects and possible risks of chemical castration, 61 patients volunteered to receive ADT in an attempt to self-alleviate excessive sexual aberrancy. Participation was completely voluntary and was not a condition of parole or probation. None of the subjects had received prior ADT or had contraindications to
Patient demographics
Baseline psychiatric diagnoses of the 38 patients who underwent ADT are shown in Table 2. All subjects were male, and the mean age was 33.4 (range 17–51) years. Six (16%) patients were under the age of 19 years at the time that they committed sexual assault; 21 (54%) patients had been convicted of sexual abuse of a child under the age of 13; three (6%) patients had been convicted of incest.
Effects of ADT on sex hormone levels
LA 3.75 mg subcutaneous depot injections were administered to patients for 3 consecutive months, followed
Discussion
ADT has been shown to reduce sexual interest, performance of sexual acts and rates of recidivism.10, 11 Independent of the strong influence that psychiatric factors play with respect to criminal sexual offences, these findings suggest that the biology of sexual drive and arousal is primarily mediated by testosterone.12, 13, 14, 15 We report similar results in that sexual drive and fantasy were suppressed after ADT despite a variety of baseline psychiatric disorders. Indeed, our expectation is
Conclusion
Progress has been made in the treatment of paraphilic and non-paraphilic sexual disorders that can be applied to sex offenders as a group. However, with deeper insight into hormonal manipulation, tailored modifications in treatment regimens for each individual will increase treatment success rates. ADT is an effective method for reducing sexual drive in Korean sex offenders with minimal side effects.
Ethical approval
None declared.
Funding
None.
Conflict of interest
All authors have no conflict of interests to declare.
Acknowledgements
On behalf of the Ministry of Justice, Korea, authors gratefully acknowledge the support and guidance of F.S. Berlin in support with establishing ‘chemical castration’ protocols.
References (24)
Drug treatment of paraphilic and nonparaphilic sexual disorders
Clin Ther
(2009)- et al.
Antiandrogens in the treatment of sexual deviations of men
J Steriod Biochem
(1975) Degarelix: an antagonist to GnRH – theoretical and treatment considerations in paraphilia
J Sex Med
(2012)- et al.
Chemical castration for sex offenders
BMJ
(2010) - et al.
Androgen deprivation treatment of sexual behavior
Adv Psychosom Med
(2011) - et al.
Does sexual offender treatment work? A systematic review of outcome evaluations
Psicothema
(2008) - et al.
Pedophilia
J Am Med Assoc
(2002) - et al.
Differential pharmacological treatment of paraphilias and sex offenders
Int J Offender Ther Comp Criminol
(2003) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis
(1994)- et al.
The Oregon depo-Provera program: a five-year follow-up
Sex Abuse
(2006)
Assessment of the Wilson Sex Fantasy Questionnaire among child molesters and nonsexual forensic offenders
Sex Abuse
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of paraphilias
World J Biol Psychiatry
Cited by (20)
Androgen Deprivation Therapy in Pedophilic Disorder: Exploring the Physical, Psychological, and Sexual Effects From a Patient's Perspective
2021, Journal of Sexual MedicineCitation Excerpt :These side effects are in line with previous research.10 As described by several authors,31,32 2 respondents in this study experienced the injection with triptorelin as painful and suggested to inject the substance in the evening. The psychological experiences of CPA differ regarding the general attitude of the respondents.
Miscellaneous Hormones
2015, Side Effects of Drugs AnnualCitation Excerpt :8 patients (24%) developed depressive symptoms. Other commonly reported adverse events included injection site pain (n = 7), myalgia (n = 4) and decreased body hair (n = 2) [8c]. A randomized, controlled trial assessed the effectiveness and safety of combined laparoscopy plus gonadotropin-releasing hormone agonist in patients with endometriosis (n = 198).
Effects of chemical castration on sex offenders in relation to the kinetics of serum testosterone recovery: Implications for dosing schedule
2014, Journal of Sexual MedicineCitation Excerpt :Although chemical castration has been mandatory for sex offenders since 2011, prior detainees at the National Forensic Hospital who were under consideration for parole or probation were candidates for voluntary treatment. We have previously reported preliminary treatment outcomes for these patients who received a 3-month on-cycle of leuprolide acetate (LA), a gonadotropin-releasing hormone (GnRH) agonist[8]. Chemical castration and the associated decrease in levels of serum testosterone (T) reduced the frequency and intensity of sexual drive, the frequency of masturbation, and the incidence of sexual fantasies; however, response rates were suboptimal, and unexpected spikes in hypersexual impulses associated with abrupt upsurges of serum T immediately following treatment cessation were documented.
An overview of crime trends and rehabilitation practices in South Korea
2024, Approaches to Offender Rehabilitation in Asian JurisdictionsCompulsive Sexual Behavior
2022, Substance and Non-Substance Related Addictions: A Global Approach